7 -8 October 2019 | Convene Convention Center | Boston | USA
2018 speakers
The LSX World Congress USA is a CxO level conference and attracts high-quality speakers from investors, biotechs and pharma creating an agenda to educate investors and corporates on the most exciting new technology and therapeutic areas in healthcare today.
Previous speakers have included:
Ivana Magovčević-Liebisch
EVP & Chief Business Officer
Ipsen
Noubar Afeyan
Founder and CEO
Flagship Pioneering
Boris Zaitra
Global Head of M&A
Roche
Neil Exter
Partner
Third Rock Ventures
James Kasuboski
Director
Boehringer Ingelheim Venture Fund USA
Michal Silverberg
Managing Director
Novartis Venture Fund
Todd Foley
Managing Director
MPM Capital
Alexandra Glucksmann
CEO
Cedilla Therapeutics
Rob Brainin
CEO
WuXi NextCODE
Michael Sherman
SVP and Chief Medical Officer
Harvard Pilgrim Health Care
Alex de Winter
Managing Director
GE Ventures
Paul Biondi
SVP, Strategy and Business Development
Bristol-Myers Squibb
Russ Johannesson
CEO
Glooko
Nigel Sheail
Global Head of M&A and BD&L
Novartis
Ed Addison
CEO
Cloud Pharmaceuticals
Sohang Chatterjee
CEO
EnBiome Therapeutics
Dennis Grishin
Co-Founder
Nebula Genomics
Philip Strandwitz
CEO
HoloBiome
Andrew Elbardissi
Principal
Deerfield
Niven Narain
CEO
Berg Health
David Donabedian
CEO
AXIAL Biotherapeutics
Douglas Russell
SVP
LaVoieHealthSciences
Josh Mandel-Brehm
CEO
CAMP4 Therapeutics
Paul Wotton
CEO
Sigilon Therapeutics
Adam Kaufman
CEO
Canary Health
Jay Goth
Managing Partner
Forentis Fund
Leila Pirhaji
Founder and CEO
ReviveMed
Todd Krueger
CEO
AOBiome Therapeutics
Brian Rye
Senior Health-Care Policy Analyst, Government Team
Bloomberg Intelligence
Jason Hafler
Senior Director of Investments
Sanofi Ventures
Alicia Irurzun-Lafitte
Principal
MS-Ventures
Mark Smith
CEO
Finch Therapeutics
Scott Shandler
CEO
Longevity Biotech
George Church
Professor of Genetics
Harvard Medical School
Joris Van Dam
Head Digital Therapeutics
Novartis
Chrissa McFarlane
CEO
Patientory
Eddie Martucci
CEO
Akili Interactive
Joseph Cawley
CSO
Encrypgen
Gini Deshpande
Founder & CEO
NuMedii
Sandy Li
Vice President
Baidu Ventures
Geoff Mackay
CEO
AvroBio
Jai Balkissoon
VP Immuno-Oncology, Global Product Development
PPD
Neil Mahapatra
Chairman
Oxford Cannabinoid Technologies
Lewis Geffen
Co-Chair, Life Science and VC & Emerging Companies Practice
Mintz Levin
Daniel O’Connell
CEO
Acumen Pharma
Dean Petkanas
CEO
Kannalife Sciences
Aradhana Sarin
SVP, Head of BD & Strategy
Alexion Pharmaceuticals
Marshall Smith
Global Head of Healthcare
Goldman Sachs
Drew Volpe
Founding Partner
First Star Ventures
Karan Wadhera
Managing Partner
Casa Verde Capital
Greg Gorgas
CEO
Artelo Biosciences
Brian Pereira
CEO
Visterra
David Benshoof Klein
CEO
Click Therapeutics
Doug Giordano
VP Business Development
Pfizer
Aaron Kantoff
Principal
Apple Tree Partners
Janna Hutz
Senior Director, Head of Human Biology & Data Science
Eisai
Giovanni Mariggi
Partner
MEdixci
Thomas Hughes
CEO
Navitor Pharmaceuticals
Jim Broderick
CEO
Palleon Pharmaceuticals
Paulina Hill
Principal
Polaris Partners
Brett Zbar
Managing Director
Foresite Capital Management
Philip Astley-Sparke
Venture Partner
Forbion Capital Partners
Mark Chin
Investment Director
Arix Bioscience
Rosemary G. Reilly
Partner
WilmerHale
Philip Lee
COO and Co-Founder
Senti Biosciences
Michael Margolis
Co-Head of Healthcare Investment Banking
Oppenheimer
Mike Fitzgerald
Managing Director
Nasdaq
Robert Ward
Chairman and Chief Executive Officer
Eloxx Pharma
Kimberly Ha
CEO & Founder
KKH Advisors
Chandra Ramanathan
VP & Head
East Cost Innovation Centre, Bayer
Marianne Hamilton Lopez
Research Director of Value-Based Payment Reform
Duke-Margolis
Arjun Goyal, VIDA Ventures
Co-Founder and Managing Director
VIDA Ventures
Jordan Saxe
Senior Managing Director, Americas
Nasdaq
Donna LaVoie
President & CEO
LaVoieHealthScience
Paul Sagan
AVP, Investor Relations and Corporate Communications
LaVoieHealthScience
The full agenda including up-to-date confirmed speakers, session content, timings and further information on the 1-2-1 partnering and networking and, satellite sessions is available on the brochure.
.jpg?width=300&height=300&name=Donna%20L.%20LaVoie,%20President%20&%20CEO,%20LaVoieHealthScience%20(1).jpg)
